Pradaxa Lawsuit to Proceed Against Boehringer Ingelheim in Del. State Court



DOCUMENTS
  • Order


WILMINGTON, Del. — A Delaware judge has refused to dismiss a Pradaxa lawsuit, finding the plaintiff adequately pled that the drug’s manufacturers failed to warn of the lack of a reversal agent and of the increased risk of gastrointestinal bleeding.

On June 29, Judge Eric M. Davis of the Delaware Superior Court further ruled that the record is too underdeveloped for a determination of whether the learned intermediary doctrine shields defendants from liability.

James Loomis began taking Pradaxa for atrial fibrillation and heart problems on April 21, 2011. He suffered a subarachnoid hemorrhage on Dec. 5, 2015 and was admitted …

FIRM NAMES
  • Butler Snow
  • McCarter & English
  • Napoli Shkolnik





UPCOMING CONFERENCES




HarrisMartin's MDL Conference: Navigating Current Mass Tort Litigation

November 30, 2022 - New York, NY
The Knickerbocker

MORE DETAILS



HarrisMartin's Webinar Series: The Hottest Upcoming Device Projects - Strattice Hernia Mesh & Exactech Hip Implants

November 09, 2022

MORE DETAILS